Stock comparison
Mettler-Toledo International
Sanofi
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
SNY
Sanofi
Market cap
$106.67B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | MTD | SNY | Winner |
|---|---|---|---|
| Warren Buffett | 69B | 61C | MTD |
| Benjamin Graham | 65B | 40D | MTD |
| Philip Fisher | 63C | 53C | MTD |
| Peter Lynch | 66B | 39D | MTD |
| Joel Greenblatt | 68B | 39D | MTD |
| Charlie Munger | 74B | 48D | MTD |
| Terry Smith | 70B | 49D | MTD |
Side-by-side metrics
| Metric | MTD | SNY |
|---|---|---|
| Market cap | $22.29B | $106.67B |
| P/E (TTM) | 25.3x | 8.6x |
| EV/EBIT | 21.6x | 10.8x |
| ROIC (TTM) | 36.09% | 11.66% |
| Gross margin | 57.79% | 71.62% |
| Net margin | 21.4% | 17.59% |
| Revenue CAGR 5y | 2.01% | 4.5% |
| EPS CAGR 5y | 6.12% | 6.47% |
| Debt / Equity | - | 0.3x |
| Dividend yield | 0.0% | 5.57% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
MTD leads on
- Debt / Equity-vs 0.3x+101%
- ROIC (TTM)36.09%vs 11.66%+68%
- Net margin21.4%vs 17.59%+18%
SNY leads on
- Dividend yield5.57%vs 0.0%+100%
- Market cap$106.67Bvs $22.29B+79%
- P/E (TTM)8.6xvs 25.3x+66%
- Revenue CAGR 5y4.5%vs 2.01%+55%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.